16,232 Shares in Dolby Laboratories, Inc. (NYSE:DLB) Purchased by Entropy Technologies LP

Entropy Technologies LP purchased a new stake in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 16,232 shares of the electronics maker's stock, valued at approximately $1,268,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. State Street Corp boosted its holdings in shares of Dolby Laboratories by 1.5% during the third quarter. State Street Corp now owns 1,931,586 shares of the electronics maker's stock valued at $147,824,000 after acquiring an additional 29,289 shares during the period. Geode Capital Management LLC raised its stake in shares of Dolby Laboratories by 4.3% during the third quarter. Geode Capital Management LLC now owns 1,538,583 shares of the electronics maker's stock valued at $117,767,000 after purchasing an additional 63,293 shares in the last quarter. Disciplined Growth Investors Inc. MN raised its stake in shares of Dolby Laboratories by 4.5% during the third quarter. Disciplined Growth Investors Inc. MN now owns 1,466,212 shares of the electronics maker's stock valued at $112,209,000 after purchasing an additional 63,589 shares in the last quarter. Boston Trust Walden Corp raised its stake in shares of Dolby Laboratories by 0.9% during the fourth quarter. Boston Trust Walden Corp now owns 1,084,700 shares of the electronics maker's stock valued at $84,715,000 after purchasing an additional 9,624 shares in the last quarter. Finally, Lord Abbett & CO. LLC raised its stake in shares of Dolby Laboratories by 5.8% during the third quarter. Lord Abbett & CO. LLC now owns 284,466 shares of the electronics maker's stock valued at $21,771,000 after purchasing an additional 15,546 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. StockNews.com cut shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st. Barrington Research restated an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Thursday. Finally, Rosenblatt Securities restated a "buy" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Thursday, January 30th.

Insiders Place Their Bets

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 12,338 shares of the business's stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total value of $963,351.04. Following the sale, the executive vice president now directly owns 62,397 shares in the company, valued at approximately $4,871,957.76. The trade was a 16.51 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 7,000 shares of the business's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $80.50, for a total transaction of $563,500.00. Following the completion of the sale, the senior vice president now owns 106,806 shares in the company, valued at approximately $8,597,883. This trade represents a 6.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 182,917 shares of company stock worth $14,861,429. 38.39% of the stock is owned by corporate insiders.

Dolby Laboratories Stock Down 0.7 %

Dolby Laboratories stock traded down $0.56 during midday trading on Friday, hitting $83.72. The company's stock had a trading volume of 440,257 shares, compared to its average volume of 466,932. The stock's 50-day moving average price is $80.26 and its 200-day moving average price is $76.09. Dolby Laboratories, Inc. has a 12 month low of $66.35 and a 12 month high of $89.66. The company has a market capitalization of $7.99 billion, a PE ratio of 30.78 and a beta of 0.98.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, February 11th. Dolby Laboratories's dividend payout ratio (DPR) is presently 48.53%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.